Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06326866
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2024-03-18
Brief Title:
Otoacoustic Emissions in Different Blood Types
Sponsor:
Istanbul University - Cerrahpasa IUC
Organization:
Istanbul University - Cerrahpasa IUC
Study Overview
Official Title:
The Association of Blood Type Differences and Signal-Noise Ratio in TEOAE and DPAOE in Individuals With Normal Hearing
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to examine whether ABO and Rhesus Rh blood group systems have an association with distortion product otoacoustic emission DPOAE and transient otoacoustic emission TEOAE amplitudes with the hypothesis of blood groups may affect hearing thresholds
Detailed Description:
Many factors have a significant impact on otoacoustic emission OAE measurement and quality of analysis Race age and gender are among the non-pathological factors To date there is clear data to demonstrate the association of blood types with OAEs The aim of our research is to investigate the relation of different blood groups ABO and Rh factors on transient evoked OAE and distortion product OAE amplitudes and inner ear potentials differences between ears and to contribute to the limited literature on cochlear hearing loss susceptibility and blood groups with the hypothesis that blood groups may be associated with hearing thresholds
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None